SNX18P24: A Drug Target / Disease Biomarker (G100419004)
SNX18P24: A Drug Target / Disease Biomarker
SNX18P24 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the SNX family of proteins, which are known for their role in intracellular signaling. SNX18P24 has been shown to play a role in a variety of physiological processes, including cell signaling, neurodegeneration, and inflammation. As a result, it has potential as a drug target or biomarker.
The SNX family of proteins was identified in the 1990s as a potential gene family that was involved in intracellular signaling. The proteins in the SNX family are characterized by the presence of a specific domain called the SNX-related module (SRM), which is a conserved region that is involved in the interaction between the protein and its ligand. The SRM is composed of a unique amino acid sequence that is characteristic of the SNX family.
SNX18P24 is a member of the SNX family of proteins and is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a 24-kDa protein that contains 214 amino acids. SNX18P24 is highly conserved, with only four% sequence identity with the mouse equivalent protein, SNX18P23.
Studies have shown that SNX18P24 is involved in a variety of physiological processes. For example, it has been shown to be involved in neurodegeneration, as a potential therapeutic target for the treatment of Alzheimer's disease. Studies have shown that SNX18P24 is involved in the regulation of cell signaling, including the production of neurotransmitters such as dopamine and GABA. It has also been shown to be involved in inflammation, as a potential therapeutic target for the treatment of autoimmune diseases.
In addition to its potential as a drug target or biomarker, SNX18P24 has also been shown to be involved in a variety of cellular processes that are important for normal development and function. For example, studies have shown that SNX18P24 plays a role in the development and maintenance of neuronal stem cells, and that it is involved in the regulation of cell proliferation. It has also been shown to be involved in the regulation of cell death, as a potential therapeutic target for the treatment of cancer.
Given the potential role of SNX18P24 in a variety of physiological processes, it is a promising target for drug development. Studies have shown that SNX18P24 can be effectively targeted with small molecules, including inhibitors of its signaling pathway. Additionally, genetic modifiers, such as RNA interference and CRISPR/Cas9, have been used to knockdown and increase the expression of SNX18P24 in various organisms.
In conclusion, SNX18P24 is a protein that is involved in a variety of physiological processes and has potential as a drug target or biomarker. Its conserved nature and its involvement in cellular processes that are important for normal development and function make it an attractive target for drug development. Further studies are needed to fully understand the role of SNX18P24 in various physiological processes and its potential as a therapeutic target.
Protein Name: Sorting Nexin 18 Pseudogene 24
The "SNX18P24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNX18P24 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
SNX18P3 | SNX19 | SNX2 | SNX20 | SNX21 | SNX22 | SNX24 | SNX25 | SNX27 | SNX29 | SNX29P1 | SNX29P2 | SNX3 | SNX30 | SNX31 | SNX32 | SNX33 | SNX4 | SNX5 | SNX6 | SNX7 | SNX8 | SNX9 | SOAT1 | SOAT2 | SOBP | SOCAR | SOCS1 | SOCS2 | SOCS2-AS1 | SOCS3 | SOCS3-DT | SOCS4 | SOCS5 | SOCS5P5 | SOCS6 | SOCS7 | SOD1 | SOD2 | SOD2-OT1 | SOD3 | Sodium channel | Sodium-Glucose Cotransporter (SGLT) | Sodium-potassium-calcium exchanger | SOGA1 | SOGA3 | SOHLH1 | SOHLH2 | Soluble (cytosolic) protein tyrosine phosphatases | Soluble guanylyl cyclase | Solute Carrier Family 12 | Solute carrier family 29 member | Somatostatin receptor | SON | SORBS1 | SORBS2 | SORBS3 | SORCS1 | SORCS2 | SORCS3 | SORCS3-AS1 | SORD | SORD2P | SORL1 | SORT1 | Sorting and assembly machinery complex | Sorting nexin | SOS1 | SOS2 | SOSS complex | SOST | SOSTDC1 | SOWAHA | SOWAHB | SOWAHC | SOWAHD | SOX1 | SOX1-OT | SOX10 | SOX11 | SOX12 | SOX13 | SOX14 | SOX15 | SOX17 | SOX18 | SOX2 | SOX2-OT | SOX21 | SOX21-AS1 | SOX3 | SOX30 | SOX30P1 | SOX4 | SOX5 | SOX5-AS1 | SOX6 | SOX7 | SOX8 | SOX9
